Alayo, Q., Ito, H., Passaro, C., Zdioruk, M., Mahmoud, A., Nakashima, H., & Chiocca, E. A. (2018). IMMU-02. ONCOLYTIC HSV THERAPY ENHANCES GLIOBLASTOMA CONTROL VIA THE EXPANSION OF FUNCTIONAL TUMOR-SPECIFIC T CELLS AND MODULATION OF MYELOID CELL POPULATION. Neuro Oncol.
Citação norma ChicagoAlayo, Quazim, Hirotaka Ito, Carmela Passaro, Mykola Zdioruk, Ahmad Mahmoud, Hiroshi Nakashima, and E Antonio Chiocca. "IMMU-02. ONCOLYTIC HSV THERAPY ENHANCES GLIOBLASTOMA CONTROL VIA THE EXPANSION OF FUNCTIONAL TUMOR-SPECIFIC T CELLS AND MODULATION OF MYELOID CELL POPULATION." Neuro Oncol 2018.
ציטוט MLAAlayo, Quazim, et al. "IMMU-02. ONCOLYTIC HSV THERAPY ENHANCES GLIOBLASTOMA CONTROL VIA THE EXPANSION OF FUNCTIONAL TUMOR-SPECIFIC T CELLS AND MODULATION OF MYELOID CELL POPULATION." Neuro Oncol 2018.